Market revenue in 2023 | USD 2.2 million |
Market revenue in 2030 | USD 5.0 million |
Growth rate | 12.3% (CAGR from 2023 to 2030) |
Largest segment | Epinephrine |
Fastest growing segment | Immunotherapies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antihistamines, Epinephrine, Immunotherapies, Other Drug Class |
Key market players worldwide | Nestle SA, Sanofi SA, DBV Technologies SA ADR, PureTech Health PLC, Regeneron Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd ADR, Protagonist Therapeutics Inc, Aravax, Alladapt Immunotherapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peanut allergy treatment market will help companies and investors design strategic landscapes.
Epinephrine was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Saudi Arabia peanut allergy treatment market based on antihistamines, epinephrine, immunotherapies, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
In Saudi Arabia, the prevalence of individuals with peanut allergy stands at 0.5%. This indicates that peanut allergies are relatively less common in the region compared to some other areas of the world. The lower prevalence suggests that peanut allergy may not be as widespread a health concern in Saudi Arabia as it is in countries where the prevalence is higher.
It is essential to consider this lower prevalence in the context of healthcare planning and resource allocation. Peanut allergy is less common, but it is still a significant issue for those affected. Healthcare providers & policymakers should ensure that necessary resources and information are available for individuals with peanut allergies, even if the overall prevalence is lower.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia peanut allergy treatment market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia peanut allergy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account